These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31834085)

  • 21. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom.
    Prah P; Petersen I; Nazareth I; Walters K; Osborn D
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):161-9. PubMed ID: 21858898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninterventional, Naturalistic, Retrospective Study to Describe Prescription Patterns of Long-Acting Injectable Antipsychotics and the Impact of Introducing a New Atypical Antipsychotic in the Spanish Province of Tarragona Catchment Area.
    Gaviria AM; Franco J; Rico G; Muntané G; Sáez C; Sánchez-Gistau V; de Pablo J; Vilella E
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28346773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of prescription practices of long acting injectable risperidone in French hospitals].
    Bret P; Heil M; Queuille E; Bret MC;
    Encephale; 2011 May; 37 Suppl 1():S58-65. PubMed ID: 21600335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.
    Fleischhacker WW; Eerdekens M; Karcher K; Remington G; Llorca PM; Chrzanowski W; Martin S; Gefvert O
    J Clin Psychiatry; 2003 Oct; 64(10):1250-7. PubMed ID: 14658976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Long-Acting Injectable Antipsychotics in Adolescents.
    Pope S; Zaraa SG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):391-4. PubMed ID: 27028966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.
    Voss EA; Ryan PB; Stang PE; Hough D; Alphs L
    Int Clin Psychopharmacol; 2015 May; 30(3):151-7. PubMed ID: 25730525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study of prescribing trends in a potentially vulnerable paediatric population from 1999 to 2012.
    Sears K; Elms S; Whitehead M; Tranmer JE; Edge DS; VanDenKerkhof EG
    Int J Pharm Pract; 2019 Dec; 27(6):545-554. PubMed ID: 31373071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
    Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.
    Carton L; Cottencin O; Lapeyre-Mestre M; Geoffroy PA; Favre J; Simon N; Bordet R; Rolland B
    Curr Pharm Des; 2015; 21(23):3280-97. PubMed ID: 26088115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study.
    Chiu YW; Huang CW; Chen PJ; Yu NW; Tsai HJ; Wu CS; Chang CM
    Int Clin Psychopharmacol; 2017 Sep; 32(5):262-270. PubMed ID: 28542035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review.
    Baeza I; Fortea A; Ilzarbe D; Sugranyes G
    Paediatr Drugs; 2023 Mar; 25(2):135-149. PubMed ID: 36662369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.
    Arora N; Knowles S; Gomes T; Mamdani MM; Juurlink DN; Carlisle C; Tadrous M
    Can J Psychiatry; 2016 Dec; 61(12):758-765. PubMed ID: 27310244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes of Croatian patients with severe mental illness towards long-acting injectable antipsychotics.
    Bjedov S; Ciglar M; Maleković H
    Psychiatr Danub; 2016 Sep; 28(3):278-283. PubMed ID: 27658837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guidelines for the use of second-generation long-acting antipsychotics].
    Jarema M; Wichniak A; Dudek D; Samochowiec J; Bieńkowski P; Rybakowski J
    Psychiatr Pol; 2015; 49(2):225-41. PubMed ID: 26093588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
    Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
    JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study.
    Fortea A; Ilzarbe D; Espinosa L; Solerdelcoll M; de Castro C; Oriolo G; Sugranyes G; Baeza I
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):252-257. PubMed ID: 29381388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion of antipsychotics in the US And French markets, 1998-2008.
    Gallini A; Donohue JM; Huskamp HA
    Psychiatr Serv; 2013 Jul; 64(7):680-7. PubMed ID: 23584568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.